単一のSCN1Aコドンのに関連した変種は,異なる機能特性を示す
Lanie N Liebovitz1, Christopher H Thompson1, Linda C Laux2
1Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Annals of clinical and translational neurology
|February 20, 2026
まとめ
SCN1A変種はを引き起こすが,その機能を予測するのは難しい. 同じコドンにおける変種でさえ,異なる効果を持つことができ,その位置を示すだけでは,病原性を予測するのに不十分です.
科学分野:
- 神経遺伝学 神経遺伝学
- 分子生物学は分子生物学である.
- エピレプシーに関する研究.
背景:
- NaV1.1チャネルをコードするSCN1Aの病原性変異は,様々な症候群を引き起こす.
- ドラヴェット症候群は機能喪失変種と関連しているが,DEEは機能獲得変種と関連している.
- SCN1A変種の病原性を予測することは,限られたデータがあるため,困難です.
研究 の 目的:
- 同じコドン (I1347) にある4つのSCN1A変異の機能特性を調査する.
- における臨床的フェノタイプと相関するチャネル機能障害.
- SCN1A変異の病原性を予測するための戦略を改善する.
主な方法:
- ヘテロロジ的に表現されたNaV1.1の変種について,全細胞のマニュアル・パッチ・クランプの記録を行った.
- NaV1.1変異タンパク質の構造モデリングのためにAlphaFold 3を使用しました.
- 患者の臨床データと文献/ClinVar症例を分析した.
主要な成果:
- SCN1A-I1347TのDEE症例を記述し,I1347N,I1347V,I1347Fの変種を持つ他の3症例を特定しました.
- 機能的研究では,I1347T,I1347V,I1347Fの混合機能とI1347Nの機能喪失が明らかになりました.
- 構造モデルでは,イソルエウシン1347の相互作用が,特にI1347N.との相互作用が乱れていることが示されました.
結論:
- 同じコードンのSCN1A変異は,多様な機能的効果を発揮することができる.
- 位置のみに基づいてSCN1A変異の病原性を予測することは信頼できない.
- 変数関数を理解するには,単純な位置を超えて包括的な分析が必要です.
関連する概念動画
Comparing Copy Number Variations and SNPs
18.8K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.8K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.0K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K
Single Nucleotide Polymorphisms-SNPs
18.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.7K
Principles of Pharmacogenetics: Types of Genetic Variants
29
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
29
Mutations
94.9K
Overview
94.9K
RNA Splicing
60.8K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.8K


